title: Body Composition and Anti-Neoplastic Treatment in Adult and Older Subjects - A Systematic Review.
abstract: The estimation of the risk of poor tolerance and overdose of antineoplastic agents protocols represents a major challenge in oncology, particularly in older patients. We hypothesize that age-related modifications of body composition (i.e. increased fat mass and decreased lean mass) may significantly affect tolerance to chemotherapy.
  
  
  
  We conducted a systematic review for the last 25 years (between 1990 and 2015), using US National library of Medicine Medline electronic bibliographic database and Embase database of cohorts or clinical trials exploring (i) the interactions of body composition (assessed by Dual X-ray Absorptiometry, Bioelectrical Impedance Analyses, or Computerized Tomography) with pharmacokinetics parameters, (ii) the tolerance to chemotherapy, and (iii) the consequences of chemotherapies or targeted therapies on body composition.
  
  
  
  Our search identified 1504 articles. After a selection (using pre-established criteria) on titles and abstract, 24 original articles were selected with 3 domains of interest: impact of body composition on pharmacokinetics (7 articles), relationship between body composition and chemotoxicity (14 articles), and effect of anti-cancer chemotherapy on body composition (11 articles). The selected studies suggested that pharmacokinetic was influenced by lean mass, that lower lean mass could be correlated with toxicity, and that sarcopenic patients experienced more toxicities that non-sarcopenic patients. Regarding fat mass, results were less conclusive. No studies specifically explored the topic of body composition in older cancer patients.
  
  
  
  Plausible pathophysiological pathways linking body composition, toxicity, and pharmacokinetics are sustained by the actual review. However, despite the growing number of older cancer patients, our review highlighted the lack of specific studies in the field of anti-neoplastic agents toxicity regarding body composition conducted in elderly.
authors.affiliation: Stéphane Gérard, CHU Purpan, Gérontopôle, Pavillon Junod, 170 avenue de Casselardit 31059 Toulouse Cedex 09, France, Tel: +33 6 78 94 44 22, Fax: +33 5 61 77 64 14, E-mail address: gerard.s@chu-toulouse.fr.
authors.forename: S
authors.initials: S
authors.lastname: Gérard
authors.forename: D
authors.initials: D
authors.lastname: Bréchemier
authors.forename: A
authors.initials: A
authors.lastname: Lefort
authors.forename: S
authors.initials: S
authors.lastname: Lozano
authors.forename: G
authors.initials: G
authors.lastname: Abellan Van Kan
authors.forename: T
authors.initials: T
authors.lastname: Filleron
authors.forename: L
authors.initials: L
authors.lastname: Mourey
authors.forename: C
authors.initials: C
authors.lastname: Bernard-Marty
authors.forename: M E
authors.initials: ME
authors.lastname: Rougé-Bugat
authors.forename: V
authors.initials: V
authors.lastname: Soler
authors.forename: B
authors.initials: B
authors.lastname: Vellas
authors.forename: M
authors.initials: M
authors.lastname: Cesari
authors.forename: Y
authors.initials: Y
authors.lastname: Rolland
authors.forename: L
authors.initials: L
authors.lastname: Balardy
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001823:Body Composition / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents